Skip to content

Clinical trials

Phase 3 Gastrointestinal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 3 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20152
20162
20201
20221
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting1
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
Pfizer2
Anthos Therapeutics, Inc.1
First Affiliated Hospital of Zhejiang University1
GlaxoSmithKline1
Sumitomo Pharma America, Inc.1
Tianjin Medical University Cancer Institute and Hospital1
Xiaonan Cui1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms11
Colorectal Neoplasms4
Digestive System Neoplasms4
Intestinal Neoplasms4
Colonic Diseases3
Digestive System Diseases3
Gastrointestinal Diseases3
Intestinal Diseases3
Rectal Diseases3
Colonic Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.